{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:23:33Z","timestamp":1767903813811,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T00:00:00Z","timestamp":1641686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T00:00:00Z","timestamp":1641686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The purpose of this study is to evaluate the impact of prenatal screening tests on prenatal diagnosis in Taiwan\u2019s 14 years from 2006 to 2019.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The prenatal screening methods evolved from the second-trimester serum screening to combined first-trimester screening (cFTS) and then followed by the non-invasive cell-free DNA prenatal test (NIPT). The data used by the Department of Statistics, the Ministry of Health and Welfare and Department of Household Registration, Ministry of the Interior public website.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This regional registry-based cohort retrospective study examined a total of 2,775,792 births from January 2006 to December 2019. The proportion of advanced maternal age (AMA) pregnancies increased from 11.63% in 2006 to 30.94% in 2019. Overall, invasive diagnostic testing was used in 87.22% of AMA pregnancies. The prenatal detection rate of trisomy 21 and 18 increased from 74.1% and 83.3% in 2006 to 96.9% and 98.8% in 2019, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>During the second-trimester and cFTS periods, the percentage of AMA pregnancies increased every year and the number of invasive procedures also accompany with increased percentage of AMA. However, during the period that NIPT were implemented, the percentage of invasive procedures decreased.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-021-04360-w","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T10:03:20Z","timestamp":1641809000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The impact of prenatal screening tests on prenatal diagnosis in Taiwan from 2006 to 2019: a regional cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Ching Hua","family":"Hsiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po Jen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven W.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woei Chyn","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran Chou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,9]]},"reference":[{"key":"4360_CR1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/bmj.297.6653.883","volume":"297","author":"NJ Wald","year":"1988","unstructured":"Wald NJ, Cuckle HS, Demsem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down syndrome in early pregnancy. BMJ. 1988;297:883\u20137.","journal-title":"BMJ"},{"key":"4360_CR2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/0029-7844(96)00042-7","volume":"87","author":"JJ Hsu","year":"1996","unstructured":"Hsu JJ, Hsieh TT, Hsieh FJ. Down syndrome screening in an Asian population using alpha fetoprotein and free b-hCG: a report of the Taiwan Down Syndrome Screening Group. Obstet Gynecol. 1996;87:943\u20137.","journal-title":"Obstet Gynecol"},{"key":"4360_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/pd.1220","volume":"25","author":"HJ Jou","year":"2005","unstructured":"Jou HJ, Kuo YS, Hsu JJ, Shyu MK, Hsieh TT, Hsieh FJ. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening. Prenat Diagn. 2005;25:665\u201370.","journal-title":"Prenat Diagn"},{"issue":"9","key":"4360_CR4","first-page":"e7542","volume":"8","author":"SY Lin","year":"2013","unstructured":"Lin SY, Hsieh CJ, Chen YL, Shaw SW, Lin MW, Chen PC, et al. The impact of Down syndrome screening on Taiwanese Down syndrome births: A nationwide retrospective study and a screening result from a single medical centre. PLoS ONE. 2013;8(9):e7542.","journal-title":"PLoS ONE"},{"key":"4360_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ajog.2004.03.090","volume":"91","author":"KH Nicolaides","year":"2004","unstructured":"Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol. 2004;91:45\u201367.","journal-title":"Am J Obstet Gynecol"},{"key":"4360_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000357564","volume":"35","author":"CH Hsiao","year":"2014","unstructured":"Hsiao CH, Cheng PJ, Shaw SW, Hsu JJ, Chen RC, Tseng YJ, et al. Extended first-trimester screening using multiple sonographic markers and maternal serum biochemistry: a five-year prospective study. Fetal Diagn Ther. 2014;35:296\u2013301.","journal-title":"Fetal Diagn Ther"},{"issue":"4","key":"4360_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.tjog.2013.10.003","volume":"52","author":"SW Shaw","year":"2013","unstructured":"Shaw SW, Chen CP, Chen PJ. From down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan. Taiwan J Obstet Gynecol. 2013;52(4):470\u20134.","journal-title":"Taiwan J Obstet Gynecol."},{"key":"4360_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1056\/NEJMra1705345","volume":"379","author":"DW Bianchi","year":"2018","unstructured":"Bianchi DW, Chiu RWK. Sequencing of circulating Cell-free DNA during pregnancy. NEJM. 2018;379:464\u201373.","journal-title":"NEJM"},{"key":"4360_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000355407","volume":"35","author":"SW Shaw","year":"2014","unstructured":"Shaw SW, Hsiao CH, Chen CY, Ren YY, Tian F, Tsai C, et al. Noninvasive prenatal testing for whole fetal chromosomal aneuploidies: a multicenter prospective cohort trial in Taiwan. Fetal Diagn Ther. 2014;35:13\u20137.","journal-title":"Fetal Diagn Ther"},{"key":"4360_CR10","unstructured":"Department of Household Registration, Minister of the Interior: https:\/\/www.ris.gov.tw\/app\/portal\/346 Accessed 1 Aug 2021."},{"key":"4360_CR11","unstructured":"Department of Statistics, Ministry of Health and Welfare https:\/\/dep.mohw.gov.tw\/dos\/cp-1720-7344-113.html Accessed 1 Aug 2021."},{"key":"4360_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1177\/000992287901800801","volume":"18","author":"NIH Consensus Development Conferences","year":"1979","unstructured":"NIH Consensus Development Conferences. Antenatal diagnosis: Amniocentesis. Clin Pediatr. 1979;18:454\u201362.","journal-title":"Clin Pediatr"},{"key":"4360_CR13","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1097\/01.AOG.0000423819.85283.f4","volume":"120","author":"American College of Obstetricians and Gynecologists","year":"2012","unstructured":"American College of Obstetricians and Gynecologists. Committee Opinion No. 545. Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol. 2012;120:1532\u20134.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"4360_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1028-4559(09)60188-1","volume":"45","author":"JJ Tseng","year":"2006","unstructured":"Tseng JJ, Chou MM, Lo FC, Lai HY, Chen MH, Ho SC. Detection of chromosome aberrations in the second trimester using genetic amniocentesis experience during 1995-2004. Taiwanese J Obstet Gynecol. 2006;45(1):39\u201341.","journal-title":"Taiwanese J Obstet Gynecol"},{"key":"4360_CR15","first-page":"979","volume":"96","author":"JFX Egan","year":"2000","unstructured":"Egan JFX, Benn P, Borgida AF, Rodis JF, Campbell WA, Vintzileos AM. Efficacy of screening for Down syndrome in the United States from 1974 to 1997. Obstet Gynecol. 2000;96:979\u201385.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"4360_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jpeds.2013.06.013","volume":"163","author":"AP Presson","year":"2013","unstructured":"Presson AP, Partyka G, Jensen KM, Devine OJ, Rasmussen SA, McCabe LL, et al. Current Estimate of Down Syndrome Population Prevalence in the United States. J Pediatr. 2013;163(4):1163\u20138.","journal-title":"J Pediatr."},{"issue":"11","key":"4360_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/bdra.23198","volume":"97","author":"CT Mai","year":"2013","unstructured":"Mai CT, Kucik JE, Isenburg J, Feldkamp ML, Marengo LK, et al. Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditions. Birth Defects Res A Clin Mol Teratol. 2013;97(11):709\u201325.","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"key":"4360_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/pd.3822","volume":"32","author":"RWK Chiu","year":"2012","unstructured":"Chiu RWK, Lo YMD. Noninvasive prenatal diagnosis empowered by high-throughput sequencing. Prenat Diagn. 2012;32:401\u20136.","journal-title":"Prenat Diagn"},{"key":"4360_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/uog.17484","volume":"50","author":"MM Gil","year":"2017","unstructured":"Gil MM, Accurti V, Santcruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50:302\u201314.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4360_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/aogs.13841","volume":"99","author":"K Gadsb\u00f8ll","year":"2020","unstructured":"Gadsb\u00f8ll K, Petersen OB, Gatinois V, Strange H, Jacobsson B, Wapner R, et al. Current use of noninvasive prenatal testing in Europe, Australia and the USA: a graphical presentation. Acta Obstet Gynecol Scand. 2020;99:722\u201330.","journal-title":"Acta Obstet Gynecol Scand."},{"key":"4360_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/uog.14911","volume":"47","author":"R Li","year":"2016","unstructured":"Li R, Wan J, Zhang Y, Fu F, Ou Y, Jing X, et al. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies. Ultrasound Obstet Gynecol. 2016;47:53\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"727","key":"4360_CR22","first-page":"e1","volume":"214","author":"ME Norton","year":"2016","unstructured":"Norton ME, Baer R, Wapner RJ, Kuppermann M, Jeffe-Pawlowski LL. Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities. Am J Obstet Gynecol. 2016;214(727):e1\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"4360_CR23","unstructured":"ACGG Practice Bulletins: Ob-Gyns Release Revised Recommendations on Screening and Testing for Genetic Disorders https:\/\/www.acog.org\/AboutACOG\/News-Room\/News-Releases\/2016\/Ob-Gyns-Release-Revised-Recommendationson-Screening-and-Testing-for-Genetic-Disorders"},{"key":"4360_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/uog.14636","volume":"45","author":"R Akolekar","year":"2015","unstructured":"Akolekar R, Beta J, Picciarelli G, Ogilvie C, D\u2019antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45:16\u201326.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4360_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/AOG.0000000000003969","volume":"136","author":"NC Rose","year":"2020","unstructured":"Rose NC, Kaimal AJ, Dugoff L, Norton ME. Screening for Fetal Chromosomal Abnormalities. ACOG Practice Bulletin No 226. Obstet Gynecol. 2020;136:1\u201322 DOI:10.1097.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"4360_CR26","doi-asserted-by":"publisher","first-page":"e0156088","DOI":"10.1371\/journal.pone.0156088","volume":"11","author":"E Sahlin","year":"2016","unstructured":"Sahlin E, Nordenskj\u00f6ld M, Gustavsson P, Wincent J, Georgsson S, Iwarsson E. Positive attitudes towards non-invasive prenatal testing (NIPT) in a Swedish cohort of 1,003 pregnant women. PLoS ONE. 2016;11(5):e0156088. https:\/\/doi.org\/10.1371\/journal.pone.0156088.","journal-title":"PLoS ONE"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04360-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-04360-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04360-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T10:05:50Z","timestamp":1641809150000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-04360-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4360"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-04360-w","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,9]]},"assertion":[{"value":"3 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Ethical approval for this study was obtained from the Institutional Review Board of Taipei City Hospital (Reg. No. TCHIRB-11008017-E). All participants were informed on the study content and provided informed written consent before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable for this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}